Etropal AD
ETR | BSOBGN
Overview
Corporate Details
- ISIN(s):
- BG1100001038
- LEI:
- 747800F04CMOK74FIJ68
- Country:
- Bulgaria
- Address:
- 191, Ruski Blvd., 2180 Etropole
- Website:
- https://www.etropal.eu/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Etropal AD is a manufacturer of disposable medical products, with a primary focus on hemodialysis equipment and consumables. The company develops, produces, and sells a range of devices designed for patients with end-stage renal disease, including capillary dialyzers, blood lines, and fistula needles. Its broader product portfolio encompasses other medical accessories such as blood taking sets, transfusion and infusion sets, catheters, tubes, and laboratory products. Additionally, some sources indicate the company is engaged in research and development activities within the field of orthopedics and traumatology.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Etropal AD.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-29 23:00 |
Earnings Release
Declaration_100о_Q2'2025_ETR.pdf
|
Bulgarian | 435.8 KB | |
| 2025-07-29 23:00 |
Legal Proceedings Report
658450-Etropal_Q2_2025_Prilojenie_4.pdf
|
Bulgarian | 128.3 KB | |
| 2025-07-29 23:00 |
Quarterly Report
658448-Management report Q2_2025_ind.pdf
|
Bulgarian | 329.6 KB | |
| 2025-07-29 23:00 |
Regulatory News Service
658444-FSC_ETR_Q2.xlsx
|
Bulgarian | 214.8 KB | |
| 2025-07-29 23:00 |
Annual / Quarterly Financial Statement
658443-provereni BEL.ETROPAL_Ind. _GFO_2025_01.01.2025_30.06.2025po MSS.pdf
|
Bulgarian | 715.8 KB | |
| 2025-07-29 23:00 |
Annual / Quarterly Financial Statement
658442-ETROPAL_Ind. GFO 2025_01.01.2025_30.06.2025_po MSS.pdf
|
Bulgarian | 306.0 KB | |
| 2025-07-29 23:00 |
Interim Report
658447-Etropal_Q2_2025_Additional_information.pdf
|
Bulgarian | 204.0 KB | |
| 2025-07-29 23:00 |
Regulatory News Service
658446-Etropal_Q2_2025_Internal_information.pdf
|
Bulgarian | 121.8 KB | |
| 2025-04-28 23:00 |
Earnings Release
Declaration_100о_Q1'2025_ETR.pdf
|
Bulgarian | 355.4 KB | |
| 2025-04-28 23:00 |
Regulatory News Service
646666-Etropal_Q1_2025_Prilojenie_4.pdf
|
Bulgarian | 108.6 KB | |
| 2025-04-28 23:00 |
Quarterly Report
646664-Management report Q1_2025_ind.pdf
|
Bulgarian | 293.4 KB | |
| 2025-04-28 23:00 |
Quarterly Report
646663-Etropal_Q1_2025_Additional_information.pdf
|
Bulgarian | 187.3 KB | |
| 2025-04-28 23:00 |
Regulatory News Service
646662-Etropal_Q1_2025_Internal_information.pdf
|
Bulgarian | 102.9 KB | |
| 2025-04-28 23:00 |
Regulatory News Service
646660-FSC_Forms.xlsx
|
Bulgarian | 216.0 KB | |
| 2025-04-28 23:00 |
Annual / Quarterly Financial Statement
646659-provereni BEL.ETROPAL_Ind. _GFO_2025_01.01.2025_31.03.2025po MSS.pdf
|
Bulgarian | 737.3 KB |
Automate Your Workflow. Get a real-time feed of all Etropal AD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Etropal AD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Spermosens_AB_publ-logo.jpg){kind=logo}
